Quest Diagnostics (NYSE: DGX) is a prominent provider of diagnostic insights, empowering individuals and healthcare organisations to enhance health outcomes. The company draws upon the world’s largest database of clinical lab results to unveil new pathways for disease identification and treatment, while also inspiring healthier behaviours and improving management across the healthcare spectrum. With a workforce of 47,000 employees, Quest Diagnostics serves approximately one in three adult Americans and supports half of the physicians and hospitals in the United States. The company’s vast capabilities in diagnostics are anchored in a commitment to transform lives through actionable health information.

Services include:
– Extensive test menu (3,000+ tests)
– Cancer diagnostics
– Anatomic pathology (AP) services
– Interpretive consultation by medical and scientific staff
– Pre-employment drugs-of-abuse screening
– Risk assessment services for the life insurance industry
– Clinical trials testing for pharmaceutical development
– State-of-the-art connectivity solutions
– Patient specimen collection at over 2,250 service centres

Quest Diagnostics continues to play a pivotal role in the healthcare landscape by providing crucial diagnostic services that aid in disease detection and management. For further details, please visit questdiagnostics.com.